Life without COX 2 inhibitors: Risks and benefits are determined by dose and potency

20062 citationsletter

Authors

Enrique J. Sánchez-Delgado · Universidad Metropolitana

Abstract

Life without COX 2 inhibitors Risks and benefits are determined by dose and potencyEditor-The paper by Kearney et al on the risk of atherothrombosis with cyclooxygenase-

Topics & Keywords

Inflammatory mediators and NSAID effects Antiplatelet Therapy and Cardiovascular Diseases Eicosanoids and Hypertension Pharmacology

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: BMJ

Volume 332, Issue 7555, pp. 1451.3-1452

DOI: 10.1136/bmj.332.7555.1451-b

Field-Weighted Citation Impact: 0.25